Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FSLE8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,055
Award facts
- Contract value 100% obligated
- $14,055.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,055.04 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on November 10, 2025. This is a firm fixed price delivery order with an ultimate completion date of November 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare systems. The company's contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical needs through the DLA Medical Supply Chain, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This award for Trulicity—a diabetes medication—exemplifies the company's ongoing role in supporting federal healthcare delivery through the DLA's pharmaceutical prime vendor programs.
Quick answers
Who was awarded contract SPE2DB26FSLE8?
SPE2DB26FSLE8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FSLE8 worth?
The government has obligated $14,055 on SPE2DB26FSLE8.
Is contract SPE2DB26FSLE8 an order under another contract?
Yes. SPE2DB26FSLE8 is a delivery order under SPE2DB20D7061, an indefinite delivery contract.
Was contract SPE2DB26FSLE8 competed?
The extent of competition for SPE2DB26FSLE8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award